Virtual Investor and Analyst Event on AX-0810

Event info

Investor
  • Title: Entering the Clinic with AX-0810: Establishing Safety, PK, and the Biomarker Roadmap for Proof of Target Engagement
  • Date & Time: November 3, 2025 beginning at 10 am ET until approximately 11:30 am ET
  • Virtual format: Webcast presentations and Q&A with covering analysts and Management
  • Registration:  https://lifescievents.com/event/agp29t7j/

KOL Biography – Prof. dr. Henkjan J. Verkade, MD, PhD

Professor Henkjan J. Verkade, MD, PhD is a pediatric gastro/hepatologist at the Beatrix Children’s Hospital of the University Medical Center Groningen, The Netherlands. He received his PhD degree in Medicine cum laude at the University of Groningen on the thesis entitled “Lipid absorption and metabolism”. He was a post-doctoral fellow at the University of Alberta, Edmonton, Canada. In 2005 he was appointed Professor of Pediatrics, pediatric gastroenterology/hepatology, at the University Medical Center Groningen. 

Professor Verkade combines clinical work in pediatric gastro/hepatology with clinical and fundamental research projects. His main research interests include intestinal lipid absorption and hepatic lipid metabolism; bile acid transport, metabolism, and signaling in health and pediatric liver disease; mechanisms and treatment of pediatric cholestatic liver diseases; development of biomarkers and novel therapies for rare inherited liver disorders. He has authored more than 300 peer-reviewed publications and more than 15 book chapters. Since 2019, he is associate editor of the Journal of Pediatric Gastroenterology and Nutrition.

You might like this